M B Khazaeli - JoVE Visualize

Showing results (71-80 of 104) with videos related to

Pageof 11

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinomaJames A Posey, Thian C Ng, Baolian Yang, et al.

Journal of Biological Response Modifiers|April 1, 1990

Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humansM B Khazaeli, R Wheeler, K Rogers, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.

American Journal of Obstetrics and Gynecology|August 1, 1986

Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancyM B Khazaeli, M M Hedayat, K D Hatch, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.

Cancer Research|July 15, 1995

Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualinK Dhingra, H Fritsche, J L Murray, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995

Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancerR F Meredith, M B Khazaeli, W E Plott, et al.

Cancer Research|August 15, 1992

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.

Clinical Nuclear Medicine|May 1, 1989

Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.

Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:

Pageof 11

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinomaJames A Posey, Thian C Ng, Baolian Yang, et al.

Journal of Biological Response Modifiers|April 1, 1990

Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humansM B Khazaeli, R Wheeler, K Rogers, et al.

Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.

American Journal of Obstetrics and Gynecology|August 1, 1986

Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancyM B Khazaeli, M M Hedayat, K D Hatch, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinomaL M Weiner, E Harvey, K Padavic-Shaller, et al.

Cancer Research|July 15, 1995

Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualinK Dhingra, H Fritsche, J L Murray, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1992

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancerR F Meredith, M B Khazaeli, T Liu, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995

Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancerR F Meredith, M B Khazaeli, W E Plott, et al.

Cancer Research|August 15, 1992

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.

Clinical Nuclear Medicine|May 1, 1989

Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanomaM Frontiera, J L Murray, L Lamki, et al.

Pageof 11